Response to 'Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer'.

Response to 'Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer'. Clin Transl Radiat Oncol. 2020 Sep;24:52 Authors: Slevin F, Rodda SL, Bownes P, Murray L, Bottomley D, Melody C, Adiotomre E, Al-Qaisieh B, Dugdale E, Hulson O, Mason J, Smith J, Henry AM PMID: 32637660 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32637660?dopt=Abstract

Source: Clinical Prostate Cancer - July 10, 2020 Category: Cancer & Oncology Authors: Slevin F, Rodda SL, Bownes P, Murray L, Bottomley D, Melody C, Adiotomre E, Al-Qaisieh B, Dugdale E, Hulson O, Mason J, Smith J, Henry AM Tags: Clin Transl Radiat Oncol Source Type: research

More News: Brachytherapy | Cancer | Cancer & Oncology | Prostate Cancer | Science